McKesson Co. (NYSE:MCK) Holdings Decreased by Strs Ohio

Strs Ohio trimmed its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 24.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 180,058 shares of the company's stock after selling 58,502 shares during the quarter. Strs Ohio owned approximately 0.14% of McKesson worth $83,363,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Legacy Financial Group LLC acquired a new position in shares of McKesson in the third quarter worth $27,000. OFI Invest Asset Management acquired a new position in shares of McKesson in the third quarter worth $26,000. BKM Wealth Management LLC acquired a new position in shares of McKesson in the fourth quarter worth $31,000. Live Oak Investment Partners acquired a new position in shares of McKesson in the fourth quarter worth $30,000. Finally, Covestor Ltd raised its holdings in shares of McKesson by 72.3% in the first quarter. Covestor Ltd now owns 81 shares of the company's stock worth $25,000 after acquiring an additional 34 shares during the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at McKesson

In other news, EVP Leann B. Smith sold 186 shares of the company's stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the sale, the executive vice president now owns 1,511 shares of the company's stock, valued at $749,456. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other McKesson news, EVP Leann B. Smith sold 186 shares of the firm's stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total transaction of $92,256.00. Following the completion of the sale, the executive vice president now owns 1,511 shares in the company, valued at approximately $749,456. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 3,473 shares of the firm's stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the sale, the chief executive officer now owns 43,445 shares of the company's stock, valued at approximately $22,789,074.75. The disclosure for this sale can be found here. Company insiders own 0.21% of the company's stock.

McKesson Trading Down 0.1 %

NYSE:MCK traded down $0.36 on Friday, hitting $523.01. 484,479 shares of the stock were exchanged, compared to its average volume of 499,445. The stock has a market cap of $68.73 billion, a PE ratio of 23.70, a PEG ratio of 1.42 and a beta of 0.45. The stock has a fifty day moving average of $523.05 and a 200-day moving average of $483.96. McKesson Co. has a fifty-two week low of $352.34 and a fifty-two week high of $543.00.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share for the quarter, topping the consensus estimate of $7.05 by $0.69. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The company had revenue of $80.90 billion during the quarter, compared to the consensus estimate of $77.93 billion. During the same quarter in the prior year, the business earned $6.90 earnings per share. The company's revenue was up 14.8% compared to the same quarter last year. As a group, analysts predict that McKesson Co. will post 27.59 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 1st were given a $0.62 dividend. This represents a $2.48 annualized dividend and a dividend yield of 0.47%. The ex-dividend date was Thursday, February 29th. McKesson's payout ratio is 11.24%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on MCK. Leerink Partnrs reissued an "outperform" rating on shares of McKesson in a report on Monday, February 26th. SVB Leerink assumed coverage on McKesson in a research note on Monday, February 26th. They issued an "outperform" rating and a $600.00 target price for the company. Argus upped their target price on McKesson from $510.00 to $570.00 and gave the company a "buy" rating in a research note on Wednesday. StockNews.com lowered McKesson from a "strong-buy" rating to a "buy" rating in a research note on Thursday, January 4th. Finally, Mizuho upped their target price on McKesson from $450.00 to $505.00 and gave the company a "neutral" rating in a research note on Friday, February 9th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $528.64.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.